NEW YORK (GenomeWeb) – Sequenom said today that it is collaborating with the University of California, San Diego in a clinical research study of its next-generation sequencing-based circulating tumor DNA assay.

Under the collaboration, UCSD's Moores Cancer Center will test the utility of the assay to profile ctDNA in blood to monitor cancer patients and assist in therapy selection.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.

Sep
07
Sponsored by
PerkinElmer

This webinar will address improvements in the library prep workflow for small RNA sequencing in serum and plasma.